FDA: Inflammation and diabetes raising red flags for tainted products

By Stephen Daniells in Laguna Beach

- Last updated on GMT

Related tags: Draft guidance, Food and drug administration

FDA: Inflammation and diabetes raising red flags for tainted products
Concerns over tainted dietary supplements are extending to products promoted for pain/inflammation and diabetes, beyond the ‘classic’ sectors of erectile dysfunction, weight loss and bodybuilding, said the new head of CFSAN at FDA.

Other areas for tainted products raising red flags for the agency included statements like “works like” or “better than” an Rx drug, labels in a foreign language or ‘broken’ English, and label contradictions or warnings, said Michael Landa, Director of the Center for Food Safety and Applied Nutrition, FDA.

Landa was speaking to attendees at the CRN’s Annual Symposium for the Dietary Supplements Industry in Laguna Beach, CA.


On the topic of the NDI draft guidance, Landa said: “FDA is planning to issue a revised draft guidance with additional Q&As addressing issues raised in the comments. This is not a withdrawal of the draft guidance, rather address where more clarity or more information is needed.”

The next meeting with industry to further discuss the document is set for October 16th​, he added.

Steve Mister, president and CEO, CRN, told attendees that the association would adopt a “spirit of compromise, where possible, if it brings predictability and certainty”.

However, he said that the synthetic botanicals issue is “an area where we will not compromise”​.

“CRN has an unwavering commitment to protect the industry where compromise is not possible.”


Good Manufacturing Practices (GMPs) continues to be a vital focus for the industry and the agency. FDA data as of  September 1, 2012, showed that there had been 289 inspections in the program activity code. Of these, there were 85 NAIs (no action indicated), 103 VAIs (voluntary action indicated), and 101 OAIs (official action indicated).

“We are now 4 or 5 years after GMPs and the numbers are discouraging,” ​said Landa.


Warning letters have also been issued for claims, with more agency activity in the claims area recently, he said.

Of note, the number of warning letters has increased in 2012, with STD claims, and concussion-prevention claims highlighted by the CFSAN chief.

“The greatest concern is claims that have an impact on public health , for example claims that may lead to a delay in treatment,” ​said Landa.

Related news

Show more

Related products

show more

The CBD opportunity is waiting…are you ready?

The CBD opportunity is waiting…are you ready?

DSM Nutritional Products | 04-Oct-2021 | Infographic

CBD is set to shake up the dietary supplements industry. And with DSM as your end-to-end partner, you can be at the forefront of CBD innovation.

Absocurcumin® - A Botanic Joint Health Ingredient

Absocurcumin® - A Botanic Joint Health Ingredient

BOTANIC HEALTHCARE (NZ) LTD | 02-Sep-2021 | Clinical Study

ABSOCURCUMIN® is a clinically proven standardized phytochemical composition derived from Turmeric, Curcuma longa. In a controlled study of 30 adults aged...

LIPINOVA® SPMs, helps resolve inflammation

LIPINOVA® SPMs, helps resolve inflammation

AZUR GLOBAL NUTRITION | 22-Jun-2021 | Product Brochure

Inflammation, specifically unresolved or uncontrolled inflammation, is widely recognized as a critical component of 75% of chronic diseases. Lipinova®...

FenuSMART® - Nature’s choice for women health

FenuSMART® - Nature’s choice for women health

Akay Natural Ingredients Private Limited | 29-Oct-2020 | Research Study

Recent clinical studies demonstrated the potential effects of a patented full-spectrum extract of fenugreek (FenuSMART®) in establishing the hormonal balance...

Follow us


View more